| 1 |
34380876 | The short form of the SUR1 and its functional implications in the damaged brain. | 2022 Mar |
1 |
| 2 |
33184150 | Long-term Follow-up of Glycemic and Neurological Outcomes in an International Series of Patients With Sulfonylurea-Treated ABCC8 Permanent Neonatal Diabetes. | 2021 Jan |
5 |
| 3 |
33185579 | Transient neonatal diabetes due to a disease causing novel variant in the ATP-binding cassette subfamily C member 8 (ABCC8) gene unmasks maturity-onset diabetes of the young (MODY) diabetes cases within a family. | 2021 Feb 23 |
3 |
| 4 |
33606663 | Differences between transient neonatal diabetes mellitus subtypes can guide diagnosis and therapy. | 2021 Apr |
1 |
| 5 |
33767884 | BIIB093 (intravenous glibenclamide) for the prevention of severe cerebral edema. | 2021 |
1 |
| 6 |
34099169 | Production and purification of ATP-sensitive potassium channel particles for cryo-electron microscopy. | 2021 |
1 |
| 7 |
34566892 | Molecular Genetics, Clinical Characteristics, and Treatment Outcomes of KATP-Channel Neonatal Diabetes Mellitus in Vietnam National Children's Hospital. | 2021 |
1 |
| 8 |
34575427 | Zoledronic Acid as a Novel Dual Blocker of KIR6.1/2-SUR2 Subunits of ATP-Sensitive K+ Channels: Role in the Adverse Drug Reactions. | 2021 Aug 27 |
1 |
| 9 |
34744976 | Pretreatment of Sulfonylureas Reducing Perihematomal Edema in Diabetic Patients With Basal Ganglia Hemorrhage: A Retrospective Case-Control Study. | 2021 |
1 |
| 10 |
34825567 | Photo-Switchable Sulfonylureas Binding to ATP-Sensitive Potassium Channel Reveal the Mechanism of Light-Controlled Insulin Release. | 2021 Dec 9 |
1 |
| 11 |
31562829 | Phenotype, genotype and glycaemic variability in people with activating mutations in the ABCC8 gene: response to appropriate therapy. | 2020 May |
2 |
| 12 |
31889684 | Effectiveness of sulfonylurea treatment in a patient with a mutation in ABCC8 (MODY12). | 2020 Dec |
1 |
| 13 |
32104032 | Recent Advances in Neonatal Diabetes. | 2020 |
1 |
| 14 |
32376986 | New insights into KATP channel gene mutations and neonatal diabetes mellitus. | 2020 Jul |
1 |
| 15 |
32418263 | Neonatal diabetes due to potassium channel mutation: Response to sulfonylurea according to the genotype. | 2020 Sep |
1 |
| 16 |
32468916 | Clinical and genetic predictors of secondary sulfonylurea failure in Type 2 diabetes patients: the SUCLINGEN study. | 2020 Jun |
1 |
| 17 |
32598150 | Structural Determinants of Insulin Release: Disordered N-Terminal Tail of Kir6.2 Affects Potassium Channel Dynamics through Interactions with Sulfonylurea Binding Region in a SUR1 Partner. | 2020 Jul 23 |
2 |
| 18 |
32792356 | Molecular and clinical characteristics of monogenic diabetes mellitus in southern Chinese children with onset before 3 years of age. | 2020 Aug |
1 |
| 19 |
33035187 | The use of glimepiride for the treatment of neonatal diabetes mellitus caused by a novel mutation of the ABCC8 gene. | 2020 Dec 16 |
1 |
| 20 |
33102403 | Neonatal Diabetes Mellitus. | 2020 |
1 |
| 21 |
33498041 | Clinical Characteristics, Molecular Features, and Long-Term Follow-Up of 15 Patients with Neonatal Diabetes: A Single-Centre Experience. | 2020 |
1 |
| 22 |
29396966 | Search for Pharmacoepigenetic Correlations in Type 2 Diabetes Under Sulfonylurea Treatment. | 2019 Apr |
3 |
| 23 |
31196892 | Neonatal diabetes mellitus due to a novel variant in the INS gene. | 2019 Aug |
1 |
| 24 |
31231590 | The influence of SLC22A1 rs622342 and ABCC8 rs757110 genetic variants on the efficacy of metformin and glimepiride combination therapy in Egyptian patients with type 2 diabetes. | 2019 |
2 |
| 25 |
28791793 | Early transition from insulin to sulfonylureas in neonatal diabetes and follow-up: Experience from China. | 2018 Mar |
1 |
| 26 |
29454299 | Congenital forms of diabetes: the beta-cell and beyond. | 2018 Jun |
1 |
| 27 |
29675256 | A case with relapsed transient neonatal diabetes mellitus treated with sulfonylurea, ending chronic insulin requirement. | 2018 |
1 |
| 28 |
29681852 | Genotypic and Phenotypic Factors Influencing Drug Response in Mexican Patients With Type 2 Diabetes Mellitus. | 2018 |
2 |
| 29 |
29844136 | A novel high-affinity inhibitor against the human ATP-sensitive Kir6.2 channel. | 2018 Jul 2 |
1 |
| 30 |
29846255 | Monogenic diabetes: the impact of making the right diagnosis. | 2018 Aug |
1 |
| 31 |
30147301 | Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date. | 2018 |
2 |
| 32 |
30637228 | Sulfonylurea and neuroprotection: The bright side of the moon. | 2018 Oct-Dec |
1 |
| 33 |
28411266 | Genetic Variation at the Sulfonylurea Receptor, Type 2 Diabetes, and Coronary Heart Disease. | 2017 Aug |
1 |
| 34 |
28511139 | A successful transition to sulfonylurea treatment in male infant with neonatal diabetes caused by the novel abcc8 gene mutation and three years follow-up. | 2017 Jul |
2 |
| 35 |
28540314 | Neonatal Diabetes: Case Report of a 9-Week-Old Presenting Diabetic Ketoacidosis Due to an Activating ABCC8 Gene Mutation. | 2017 Jan-Mar |
2 |
| 36 |
28587604 | KCNJ11, ABCC8 and TCF7L2 polymorphisms and the response to sulfonylurea treatment in patients with type 2 diabetes: a bioinformatics assessment. | 2017 Jun 6 |
4 |
| 37 |
29035201 | Anti-diabetic drug binding site in a mammalian KATP channel revealed by Cryo-EM. | 2017 Oct 24 |
1 |
| 38 |
27161588 | The shifting landscape of KATP channelopathies and the need for 'sharper' therapeutics. | 2016 May |
1 |
| 39 |
27180666 | [Pharmacogenetics of oral antidiabetic treatment]. | 2016 Mar |
1 |
| 40 |
27329029 | Clinical and genetic features of Argentinian children with diabetes-onset before 12months of age: Successful transfer from insulin to oral sulfonylurea. | 2016 Jul |
1 |
| 41 |
27538677 | ABCC8-Related Maturity-Onset Diabetes of the Young (MODY12): Clinical Features and Treatment Perspective. | 2016 Sep |
1 |
| 42 |
27849623 | Successful transition to sulfonylurea therapy in two Iraqi siblings with neonatal diabetes mellitus and iDEND syndrome due to ABCC8 mutation. | 2016 Dec 1 |
2 |
| 43 |
26388896 | Successful sulfonylurea treatment in a patient with permanent neonatal diabetes mellitus with a novel KCNJ11 mutation. | 2015 Aug |
1 |
| 44 |
26392140 | Topical sulfonylurea as a novel therapy for hypertrichosis secondary to diazoxide, and potentially for other conditions with excess hair growth. | 2015 Dec |
1 |
| 45 |
26767545 | Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas? | 2015 |
1 |
| 46 |
24150606 | OATP1B3 is expressed in pancreatic β-islet cells and enhances the insulinotropic effect of the sulfonylurea derivative glibenclamide. | 2014 Feb |
1 |
| 47 |
24468609 | A novel activating ABCC8 mutation underlying neonatal diabetes mellitus in an infant presenting with cerebral sinovenous thrombosis. | 2014 May |
1 |
| 48 |
24849284 | Carbamazepine inhibits ATP-sensitive potassium channel activity by disrupting channel response to MgADP. | 2014 |
2 |
| 49 |
25052923 | Permanent neonatal diabetes mellitus in China. | 2014 Jul 23 |
1 |
| 50 |
25238204 | Sulfonylurea treatment before genetic testing in neonatal diabetes: pros and cons. | 2014 Dec |
1 |